Clinical Trial
design services
Statistical input to study design options
Authoring the statistical sections of the protocol
Full review of the protocol, including important non-statistical issues
CRF and data management plan review
Statistical support for study investigator meetings
JAR Statistics offers extensive experience of design and interpretation of studies from all phases of drug development, with particular expertise in Phase II and Phase III oncology studies.